Heart failure with preserved ejection fraction based on aging and comorbidities

被引：0
作者：
Ying Lin
Shihui Fu
Yao Yao
Yulong Li
Yali Zhao
Leiming Luo
机构：
[1] Hainan Hospital of Chinese People’s Liberation Army General Hospital,Department of Cardiology
[2] Chinese People’s Liberation Army General Hospital,Department of Geriatric Cardiology
[3] Medical School of Duke University,Centre for the Study of Ageing and Human Development and Geriatrics Division
[4] National School of Development,Centre for Healthy Ageing and Development Studies
[5] Peking University,Central Laboratory
[6] Hainan Hospital of Chinese People’s Liberation Army General Hospital,undefined
来源：
Journal of Translational Medicine | / 19卷
关键词：
Aging; Comorbidities; Diagnosis; Heart failure with preserved ejection fraction; Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Heart failure (HF) with preserved ejection fraction (HFpEF) is a leading cause of hospitalizations and mortality when diagnosed at the age of ≥ 65 years. HFpEF represents multifactorial and multisystemic syndrome and has different pathophysiology and phenotypes. Its diagnosis is difficult to be established based on left ventricular ejection fraction and may benefit from individually tailored approaches, underlying age-related changes and frequent comorbidities. Compared with the rapid development in the treatment of heart failure with reduced ejection fraction, HFpEF presents a great challenge and needs to be addressed considering the failure of HF drugs to improve its outcomes. Further extensive studies on the relationships between HFpEF, aging, and comorbidities in carefully phenotyped HFpEF subgroups may help understand the biology, diagnosis, and treatment of HFpEF. The current review summarized the diagnostic and therapeutic development of HFpEF based on the complex relationships between aging, comorbidities, and HFpEF.
引用
收藏
相关论文
共 377 条
  • [21] Fu S(2019)Heart failure with preserved ejection fraction: a review of cardiac and noncardiac pathophysiology Front Physiol 10 638-2320
  • [22] Xie L(2014)Right ventricular function in heart failure with preserved ejection fraction: a community-based study Circulation 130 2310-1259
  • [23] Li D(2015)Myocardial stifness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin Circulation 131 1247-94
  • [24] Ye P(2009)Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs Circ Res 104 87-302
  • [25] Luo L(2012)Molecular and cellular basis for diastolic dysfunction Curr Heart Fail Rep 9 293-2372
  • [26] Borlaug BA(2018)Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium J Am Coll Cardiol 71 2360-1569
  • [27] Kaye DM(2018)The epicardial adipose inflammatory triad: coronary atherosclerosis, atrial fibrillation, and heart failure with a preserved ejection fraction Eur J Heart Fail 20 1567-2334
  • [28] Marwick TH(2012)Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction Circulation 126 2324-1584
  • [29] Iyngkaran P(2013)Overall and abdominal obesity indicators had different association with central arterial stiffness and hemodynamics independent of age, sex, blood pressure, glucose, and lipids in Chinese community-dwelling adults Clin Interv Aging 8 1579-1508
  • [30] Anavekar NS(2014)Relation of proinflammatory activity of epicardial adipose tissue to the occurrence of atrial fibrillation Am J Cardiol 113 1505-272
12345678910